Total medical devices industry deals in January 2019 worth $3.61bn were announced, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 188.8% over the previous month and a drop of 17.2% when compared with the last 12-month average of $4.36bn.
In terms of number of deals, the sector saw a rise of 11.43% over the last 12-month average with 117 deals against the average of 106 deals.
In value terms, North America led the activity with deals worth $3.11bn.
The top five medical devices deals accounted for 71.43% of the overall value in the sector globally during January 2019.
Medical devices industry deals in January 2019: Top deals
The combined value of the top five medical devices deals stood at $2.58bn, against the overall value of $3.61bn recorded for the month. The top announced medical devices deal tracked by GlobalData in January 2019 was PHC’s $1.14bn asset transaction with Thermo Fisher Scientific .
CICC Capital Management , LB Investment , Meinian Onehealth Healthcare (Group ), Ping An Insurance (Group) of China, Samsung Ventures Investment , Tasly Pharmaceutical Group’s $100m venture financing of Hangzhou KangSheng Health Management Consulting and Alychlo ‘s venture financing of Sophia Genetics for $77m held fourth and fifth positions, respectively.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
Verdict’s parent company GlobalData plc provides business information to 4,000 of the world’s largest companies.